<?xml version="1.0" encoding="UTF-8"?>
<p>CPT has a very long history of use in the treatment of infectious disease. Its use has been well documented during the outbreak of many diseases at various periods, including spanish Influenza A (H1N1) infections in 1915 to 1917,
 <xref rid="jmv25961-bib-0011" ref-type="ref">
  <sup>11</sup>
 </xref> severe acute respiratory syndrome (SARS) in 2003,
 <xref rid="jmv25961-bib-0012" ref-type="ref">
  <sup>12</sup>
 </xref> pandemic 2009 influenza A (H1N1),
 <xref rid="jmv25961-bib-0013" ref-type="ref">
  <sup>13</sup>
 </xref> avian influenza A (H5N1),
 <xref rid="jmv25961-bib-0014" ref-type="ref">
  <sup>14</sup>
 </xref> several hemorrhagic fevers such as Ebola,
 <xref rid="jmv25961-bib-0015" ref-type="ref">
  <sup>15</sup>
 </xref> and other viral infections. In addition, studies show convalescent plasma antibodies that can limit the virus reproduction in the acute phase of infection and help clear the virus, which is beneficial to the rapid recovery of the disease.
 <xref rid="jmv25961-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref>
</p>
